NCT05916040View on ClinicalTrials.gov

Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy

RecruitingOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 28, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2030

Conditions
Rectal Cancer
Interventions
DEVICE

Radiotherapy with MRIdian with simultaneous integrated boost

radiotherapy during 5 days given in 5 weekdays with simultaneous integrated boost

OTHER

Questionnaires before, during and after radiotherapy

"Questionnaires consisting of 3 quality of life scales and 1 mental state scale:~* EORTC QLQ-C30~* EORTC QLQ-CR29~* Low Anterior Resection Syndrome Score (LARS) questionnaire~* Hospital Anxiety and Depression Scale (HADS) questionnaire"

Trial Locations (1)

1090

RECRUITING

UZ Brussel - Dienst Radiotherapie, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER